International Journal of Cancer Management

Published by: Kowsar

Analyzing the Long-Term Survival of Patients with Colorectal Cancer: A Study Using Parametric Non-Mixture Cure Rate Models

Mehdi Azizmohammad Looha 1 , Elaheh Zarean 2 , Mohamad Amin Pourhoseingholi 3 , Seyyed Vahid Hosseini 4 , Tara Azimi 5 and Soheila Khodakarim 6 , *
Authors Information
1 Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Modeling in Health Research Center, School of Public Health, Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
5 School of Public Health, University of Alberta, Edmonton, Alberta, Canada
6 Department of Epidemiology, School of Public Health, School of Paramedical Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: September 2018, 11 (9); e81681
  • Published Online: September 18, 2018
  • Article Type: Research Article
  • Received: July 3, 2018
  • Revised: August 21, 2018
  • Accepted: August 25, 2018
  • DOI: 10.5812/ijcm.81681

To Cite: Azizmohammad Looha M, Zarean E , Pourhoseingholi M A, Hosseini S V, Azimi T, et al. Analyzing the Long-Term Survival of Patients with Colorectal Cancer: A Study Using Parametric Non-Mixture Cure Rate Models, Int J Cancer Manag. 2018 ; 11(9):e81681. doi: 10.5812/ijcm.81681.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: First results from a population-based cancer registry. East Mediterr Health J. 2009;15(6):1426-31. [PubMed: 20218134].
  • 2. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H. Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci. 2011;16(9):1228-33. [PubMed: 22973394]. [PubMed Central: PMC3430050].
  • 3. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91. doi: 10.1136/gutjnl-2015-310912. [PubMed: 26818619].
  • 4. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006;355(24):2551-7. doi: 10.1056/NEJMcp063038. [PubMed: 17167138].
  • 5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. doi: 10.3322/CA.2007.0010. [PubMed: 18287387].
  • 6. Azadeh S, Moghimi-Dehkordi B, Fatem SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: An epidemiological study. Asian Pac J Cancer Prev. 2008;9(1):123-6. [PubMed: 18439090].
  • 7. Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FS. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52-7. [PubMed: 24834288]. [PubMed Central: PMC4017539].
  • 8. Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, et al. Colorectal cancer survival in the USA and Europe: A CONCORD high-resolution study. BMJ Open. 2013;3(9). e003055. doi: 10.1136/bmjopen-2013-003055. [PubMed: 24022388]. [PubMed Central: PMC3773629].
  • 9. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805-8. [PubMed: 11009523]. [PubMed Central: PMC1118620].
  • 10. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1695-8. doi: 10.1158/1055-9965.EPI-09-0186. [PubMed: 19505901].
  • 11. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6):366-78. doi: 10.3322/caac.20038. [PubMed: 19897840].
  • 12. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210. [PubMed: 25220842].
  • 13. Shin A, Jung KW, Won YJ. Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore. World J Gastroenterol. 2013;19(7):979-83. doi: 10.3748/wjg.v19.i7.979. [PubMed: 23467631]. [PubMed Central: PMC3582009].
  • 14. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in iran: A review. Arch Iran Med. 2009;12(2):161-9. [PubMed: 19249887].
  • 15. Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: Retrospective analysis of the WHO mortality database. BMJ. 2015;351:h4970. doi: 10.1136/bmj.h4970. [PubMed: 26442928]. [PubMed Central: PMC4595561].
  • 16. Sung JJ, Lau JY, Goh KL, Leung WK; Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol. 2005;6(11):871-6. doi: 10.1016/S1470-2045(05)70422-8. [PubMed: 16257795].
  • 17. Dianatinasab M, Ghaem H, Rezaianzadeh A, Hosseini SV, Khazraei H. Colorectal cancer mortality in Shiraz, Iran. Asian Pac J Cancer Prev. 2016;17(8):4101-5. [PubMed: 27644668].
  • 18. Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am. 2015;29(1):1-27. doi: 10.1016/j.hoc.2014.09.005. [PubMed: 25475570]. [PubMed Central: PMC4258898].
  • 19. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008;23(7):683-8. doi: 10.1007/s00384-008-0463-7. [PubMed: 18330578].
  • 20. Moradi A, Khayamzadeh M, Guya M, Mirzaei HR, Salmanian R, Rakhsha A, et al. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev. 2009;10(4):583-6. [PubMed: 19827873].
  • 21. Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8(3):576-94. doi: 10.1093/biostatistics/kxl030. [PubMed: 17021277].
  • 22. Gauci D, Allemani C, Woods L. Population-level cure of colorectal cancer in Malta: An analysis of patients diagnosed between 1995 and 2004. Cancer Epidemiol. 2016;42:32-8. doi: 10.1016/j.canep.2016.03.001. [PubMed: 26999401].
  • 23. Zarean E, Yaseri M, Mahmoodi M, Entezar Mahdi R. [Factors affecting long-term survival rate with cure fraction using the mixture cure cox model in patients with gastric cancer in East-Azerbaijan province, Iran]. J Sch Public Health Institute Public Health Res (SJSPH). 2018;15(4):337-50. Persian.
  • 24. Zarean E, Azizmohammad Looha M, Amini P, Mahmoudi M, Azimi T. Factors affecting long-survival of patients with esophageal cancer using non-mixture cure fraction model. Asian Pac J Cancer Prev. 2018;19(6):1677-83. doi: 10.22034/APJCP.2018.19.6.1677. [PubMed: 29938465]. [PubMed Central: PMC6103597].
  • 25. Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011;11:96. doi: 10.1186/1471-2288-11-96. [PubMed: 21696598]. [PubMed Central: PMC3145604].
  • 26. Amico M, Van Keilegom I. Cure models in survival analysis. Annu Rev Stat Appl. 2018;5(1):311-42. doi: 10.1146/annurev-statistics-031017-100101.
  • 27. Chen MH, Ibrahim JG, Sinha D. A new bayesian model for survival data with a surviving fraction. J Am Stat Assoc. 1999;94(447):909-19. doi: 10.1080/01621459.1999.10474196.
  • 28. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003;90(6):711-5. doi: 10.1002/bjs.4098. [PubMed: 12808619].
  • 29. Amri R, Stronks K, Bordeianou LG, Sylla P, Berger DL. Gender and ethnic disparities in colon cancer presentation and outcomes in a US universal health care setting. J Surg Oncol. 2014;109(7):645-51. doi: 10.1002/jso.23567. [PubMed: 24474677].
  • 30. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union internationale contre le cancer and the American joint committee on cancer. Cancer. 1997;80(9):1803-4. [PubMed: 9351551].
  • 31. Oh HS, Chung HJ, Kim HK, Choi JS. Differences in overall survival when colorectal cancer patients are stratified into new TNM staging strategy. Cancer Res Treat. 2007;39(2):61-4. doi: 10.4143/crt.2007.39.2.61. [PubMed: 19746212]. [PubMed Central: PMC2739317].
  • 32. Li Q, Cai G, Li D, Wang Y, Zhuo C, Cai S. Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER database. PLoS One. 2014;9(4). e93756. doi: 10.1371/journal.pone.0093756. [PubMed: 24699879]. [PubMed Central: PMC3974782].
  • 33. Chu QD, Zhou M, Medeiros KL, Peddi P, Kavanaugh M, Wu XC. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. BMC Cancer. 2016;16:460. doi: 10.1186/s12885-016-2446-3. [PubMed: 27412163]. [PubMed Central: PMC4944507].
  • 34. Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg. 1998;85(2):246-8. doi: 10.1046/j.1365-2168.1998.00507.x. [PubMed: 9501827].
  • 35. Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, et al. Prognostic impact of tumor location in stage IV colon cancer: A propensity score analysis in a multicenter study. Int J Surg. 2014;12(9):925-30. doi: 10.1016/j.ijsu.2014.07.270. [PubMed: 25091400].
  • 36. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15(9):2388-94. doi: 10.1245/s10434-008-0015-y. [PubMed: 18622647]. [PubMed Central: PMC3072702].
  • 37. Jess P, Hansen IO, Gamborg M, Jess T, Danish Colorectal Cancer G. A nationwide danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open. 2013;3(5). doi: 10.1136/bmjopen-2013-002608. [PubMed: 23793665]. [PubMed Central: PMC3657647].
  • 38. Ishihara S, Watanabe T, Akahane T, Shimada R, Horiuchi A, Shibuya H, et al. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis. 2012;27(3):371-9. doi: 10.1007/s00384-011-1343-0. [PubMed: 22052041].
  • 39. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27(31):5131-7. doi: 10.1200/JCO.2009.22.4949. [PubMed: 19738119]. [PubMed Central: PMC2773472].
  • 40. Poeschl EM, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, et al. Perineural invasion: Correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol. 2010;28(21):e358-60. author reply e361-2. doi: 10.1200/JCO.2009.27.3581. [PubMed: 20385977].
  • 41. Yamada S, Fujii T, Hirakawa A, Kanda M, Sugimoto H, Kodera Y. Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. Langenbecks Arch Surg. 2016;401(8):1143-52. doi: 10.1007/s00423-016-1412-5. [PubMed: 27048402].
  • 42. Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg. 2010;34(4):768-75. doi: 10.1007/s00268-009-0336-4. [PubMed: 20052471].
  • 43. Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis. 2009;24(11):1297-302. doi: 10.1007/s00384-009-0738-7. [PubMed: 19479270].
  • 44. Zare Mirzaei A, Abdorrazaghi F, Lotfi M, Kazemi Nejad B, Shayanfar N. Prognostic value of lymph node ratio in comparison to lymph node metastases in stage III colon cancer. Iran J Pathol. 2015;10(2):127-35. [PubMed: 26351473]. [PubMed Central: PMC4539757].
  • 45. Peschaud F, Benoist S, Julie C, Beauchet A, Penna C, Rougier P, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg. 2008;248(6):1067-73. doi: 10.1097/SLA.0b013e31818842ec. [PubMed: 19092352].
  • 46. Rausei S, Iovino D, Tenconi S, Mangano A, Inversini D, Boni L, et al. Impact of lymph node ratio on survival of colorectal cancer patients. Int J Surg. 2013;11 Suppl 1:S95-9. doi: 10.1016/S1743-9191(13)60026-6. [PubMed: 24380564].
  • 47. Jun KH, Jung H, Baek JM, Chin HM, Park WB. Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg. 2009;394(4):631-5. doi: 10.1007/s00423-008-0417-0. [PubMed: 18791731].
  • 48. Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Langner C. Value of tumor size as a prognostic variable in colorectal cancer: A critical reappraisal. Am J Clin Oncol. 2011;34(1):43-9. doi: 10.1097/COC.0b013e3181cae8dd. [PubMed: 20101166].
  • 49. Ostenfeld EB, Norgaard M, Thomsen RW, Iversen LH, Jacobsen JB, Sogaard M. Comorbidity and survival of danish patients with colon and rectal cancer from 2000-2011: A population-based cohort study. Clin Epidemiol. 2013;5(Suppl 1):65-74. doi: 10.2147/CLEP.S47154. [PubMed: 24227924]. [PubMed Central: PMC3820479].
  • 50. van Eeghen EE, Bakker SD, van Bochove A, Loffeld RJ. Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol. 2015;6(6):605-12. doi: 10.3978/j.issn.2078-6891.2015.070. [PubMed: 26697191]. [PubMed Central: PMC4671847].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments